Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Marker Therapeutics Inc. (NASDAQ: MRKR) Receives FD Approval For MT-601 IND…
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces PALISADE-1 Phase 3 Study Findings…
ObsEva SA (NASDA: OBSV) Announce Corporate Restructuring And Resignation of Chief…
Evofem Bioscience Inc. (NASDAQ: EVFM) Commends US Multi-Agencies For Clarifying Birth…
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Partners with Kenya Medical Research…
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
GIS
Tag: GIS
Unusual call activity (GIS, DBX, DDOG, X)
Matt Wade
-
January 2, 2020
0
Recent Post
Marker Therapeutics Inc. (NASDAQ: MRKR) Receives FD Approval For MT-601 IND...
Gavins Felicity
-
August 15, 2022
0
Marker Therapeutics Inc. (NASDAQ: MRKR) has announced that the US FD has approved its Investigational New Drug application for MT -601 for treatment of...
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces PALISADE-1 Phase 3 Study Findings...
August 12, 2022
ObsEva SA (NASDA: OBSV) Announce Corporate Restructuring And Resignation of Chief...
August 11, 2022
Why Crypto Stocks May be the Best Route to Monetizing the...
August 10, 2022
Evofem Bioscience Inc. (NASDAQ: EVFM) Commends US Multi-Agencies For Clarifying Birth...
August 10, 2022
